Company Search:
Advanced Search
Sponsored Links
Novavax, Inc. Company Snapshot
Novavax, Inc. operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Novavax with three other companies in this sector in UNITED STATES : Alector Inc (2019 sales of $21.22 million of which 100% was Biopharmacy), Scholar Rock Holding Corp ($20.49 million of which 100% was Bio), and Editas Medicine Inc ($20.53 million of which 100% was Pharmaceutical).

Sales Analysis. Novavax reported sales of $18.66 million for the year ending December of 2019. This represents a sharp decrease of 45.6% versus 2018, when the company's sales were $34.29 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Novavax, Inc.
  Stock Performance Chart for Novavax, Inc.
  Stock Data: Recent Stock Performance:
  Current Price (1/15/2021): 127.43
(Figures in U.S. Dollars)
1 Week 4.6%   13 Weeks 2.1%  
4 Weeks 19.0%   52 Weeks 2,120.0%  
Novavax, Inc. Key Data:
  Ticker: NVAX Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2019 Sales 18,662,000
(Year Ending Jan 2020).
Employees: 165
  Currency: U.S. Dollars Market Cap: 8,018,849,414
  Fiscal Yr Ends: December Shares Outstanding: 62,927,485
  Share Type: Common Closely Held Shares: 623,973
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.